Clinical Council


A/Professor Andrew Wong (Councillor) 


Dr Andrew Wong  is the current Chair of the Curriculum Development Committee of the Australasian Stroke Academy, effective as of May 2016 to present.

Dr Andrew Wong is a Neurologist and Stroke Physician working in Brisbane, Queensland, Australia. He is the director of Neurology and Stroke at the Royal Brisbane and Women's Hospital. His clinical and research interests are focussed on stroke, which was the subject of his PhD. He is also actively involved in education; apart from presenting at local and national meetings, he organises various educational events for Queensland neurology registrars and consultants.


A/Professor Henry Ma (Councillor) 


Dr Henry Ma is a stroke neurologist at Monash Health. He is also adjunct senior lecturer in the Acute Stroke and Imaging division within the Stroke and Ageing Research Group (STAR) in the Dept. of Medicine, Southern Clinical School, Monash University. His PhD is on "Imaging the Penumbra in Acute Stroke" at the University of Melbourne. His special research interests are in the imaging of the ischaemic penumbra and acute stroke trials. He has published many papers on these topics and is currently the international coordinator for EXTEND, a multicentred thrombolysis trial in acute stroke. He is the Director of Physician Training at Monash Medical Centre and serves as a member of the National Examiner Panel for the Royal Australasian College of Physician (RACP)


Dr Ben Clissold (Councillor)


Dr Clissold is a stroke neurologist at Monash Health and Barwon Health in Victoria, Australia. He is a graduate of Monash University and has completed his doctoral research in relation to patterns of stroke admissions to Victorian Hospitals using data linkage methods. His current clinical roles include as the head of inpatient services for neurology at Barwon Health in Victoria, one of Australia?s largest regional health services. He works in both rural and metropolitan acute stroke services at both Monash Health and Barwon Health, and is involved in providing acute intravenous thrombolysis and endovascular clot retrieval. He is a member of the Victorian Stroke Clinical Network, and is actively involved in clinical trial work including the current EXTEND IV and TASTE thrombolysis trials. He also has ongoing research interests in data pattern recognition and cardiac risk factors for acute stroke and holds honorary fellow / lecturer positions at Monash and Deakin Universities. He recently joined the Victorian Stroke Telemedicine Service. 

bern-001.jpg - large

Professor. Bernard Yan (Councillor) 


Since commencing employment in 2005 at the Department of Medicine, University of Melbourne and the Department of Neurology, Royal Melbourne Hospital, A/Prof. Yan has held dual appointments of Endovascular Neurointerventionist and Neurologist. His current administrative roles include Treasurer of the World Stroke Organization (2014 to present) and founder and organizer of the basic physician trainee workshops (2012 to present) and the Australia and China Training Initiative in Neurology (2010 to present). He has a strong academic interest in cerebrovascular disease research. He has published 149 academic papers in peer-reviewed medical journals. Bernard Yan is actively involved in investigator-driven and industry-sponsored multi-centre clinical trials. He is the principal investigator of several international studies in cerebrovascular diseases. One of his key research interests is in the development of portable mobile wireless sensors for the monitoring of patients with neurological diseases. These devices are designed to monitoring the motor recovery of stroke patients and the epileptic seizure frequency of patients with epilepsy. His other research interest is in the elucidation of genetically-determined responsiveness to antiplatelet therapy (aspirin and clopidogrel) in cerebrovascular disease. The test of responsiveness to antiplatelets is performed by an aggregometer. Current research effort is directed towards the clarification of antiplatelet responsiveness and genetic polymorphisms. 

photo.JPG - large

A/Professor. Andrew Lee (Councillor)

Dr Andrew Lee is a stroke trained neurologist and is currently the Regional Director of Stroke Medicine, Adelaide Health Service, Southern Cluster based at Flinders Medical Centre. He completed his medical training at the University of Adelaide, and both an Internal Medicine and Neurology residency at the Queen Elizabeth Hospital. He continued on to a Stroke Research Fellowship in the Department of Cerebrovascular Neurology, at the Johns Hopkins University School of Medicine and Hospital under the mentorship of Professor Argye Hillis. He received a Masters of Public Health from the Bloombergs School of Public Health, Johns Hopkins University with a capstone project on the management of TIA. On returning to Adelaide he was awarded a NHMRC ? NICS Fellowship to research more efficient ways of implementing thrombolysis in acute ischemic stroke. He has authored more than 20 articles on stroke related topics and has an interest in retinovascular disorders as well as perfusing imaging and amyloid angiopathy. He is the current chair of the Australian Stroke Unit Network and chairs the education and workforce committee of the Australian Stroke Coalition.



Professor. Mark Parsons (Councillor)


Prof Parsons is a post-doctoral researcher, whose work using magnetic resonance and CT imaging techniques to study stroke pathophysiology and new therapeutic approaches is internationally recognised. He has published a number of first author papers in prestigious international journals, three of which have been keynote publications in the high impact Annals of Neurology, each accompanied by an editorial. Prof. Parsons PhD thesis detailed the use of modern, multimodality MRI techniques in acute stroke, from which he published several first author papers in high-impact international journals. He had particular interests in the effects of thrombolysis on the ischaemic penumbra, showing that intravenous tPA salvaged significant brain tissue in this critical region and these benefits correlated with improved clinical outcomes.

Prof. Parsons has also demonstrated the ability to translate fundamental research in the laboratory and clinic into solutions with direct practical application that can be incorporated into clinical practice. He has experience in the re-design and evaluation of health systems, often a critical step in the implementation of complex therapies such as stroke thrombolysis. Prof Parsons led the development of an ambulance protocol in the Hunter Region for the rapid identification, pre-hospital notification, and rapid transport of potential thrombolysis patients to a specialist stroke centre. This protocol led to a substantial increase in patients treated with thrombolytic therapy in the Hunter and on the Central Coast.

Dr Elizabeth Pepper (Councillor)


Dr Elizabeth Pepper is a neurologist with clinical interest in the areas of stroke, movement disorders and general neurology, as well as having an interest in general medicine. She works in Newcastle NSW at John Hunter Hospital and the Calvary Mater Newcastle (CMN), a university teaching hospital with a focus on general medicine and cancer care. She is the director of the stroke unit at the CMN, where she is the local principal investigator for multicentre stroke secondary prevention trials, and is a member of the stroke society of Australasia and the Australasian Stroke Trialists Network. Her research experience also includes work as an associate investigator in several stroke imaging trials with Professor Mark Parsons.




Professor. Stephen Davis ( Patron)

Professor Stephen Davis is the inaugural Professor of Translational Neuroscience at the University of Melbourne. He is based at the Royal Melbourne Hospital (RMH) where he is the Director of Neurosciences and Continuing Care, Director of Neurology and Director of the Melbourne Brain Centre (MBC) at the RMH. The MBC at RMH is funded a Centre of Research Excellence (CRE) grant from the NHMRC. He is the current President of the World Stroke Organization and Co-Chair of the World Stroke Academy. He is the immediate past-President of the Australian and New Zealand Association of Neurologists (ANZAN) and a past-President of the Stroke Society of Australasia. He was the first Co-chair of the Australasian Stroke Trials network and has extensive experience in stroke trials. He is the Co-Chair, with Geoffrey Donnan, of Neuroscience Trials Australia (NTA). He is a Consulting Editor for Stroke and on a number of other editorial boards. He has been a trustee of the RMH Neuroscience Foundation since its formation in 1992. He was given the M.J. Eadie Award in 2004 by the Australian and New Zealand Association of Neurologists for career achievements in neuroscience research and the Victorian Health Minister?s Award in 2008 for outstanding individual achievement, in the Victorian Public Healthcare awards. He was the 2011 recipient of the William Feinberg Award from the American Stroke Association for excellence in clinical stroke research. He was the 2011 recipient of the Bethlehem Griffiths Research Foundation medal. In 2012, he has been given the E Graeme Robertson award by the Australian and New Zealand Association of Neurologists for career achievements for Neuroscience. He is the joint recipient of a current NHMRC program grant in stroke and the Principal Investigator of the NHMRC grant in Clinical Research Excellence at the Royal Melbourne Hospital. He has co-authored 3 books, numerous book chapters, and over 340 peer-reviewed papers